Last update June 10, 2009

Deoxycoformycin

Very High Risk

Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding. Read the Comment.

Drug is cleared from the body in 8 elimination half-lives.

Return to breastfeeding is likely safe after 2 days of pumping-discarding of the milk.

Alternatives

We do not have alternatives for Deoxycoformycin.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Deoxycoformycin is also known as Pentostatin.


Group

Deoxycoformycin belongs to this group or family:

Tradenames

Main tradenames from several countries containing Deoxycoformycin in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 268 daltons
Protein Binding 4 %
6 hours

References

  1. Johnson SA. Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies. Clin Pharmacokinet. 2000 Abstract

Total visits

1,929

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM